Home / Markets / Capital Market News / Lincoln Pharmaceuticals consolidated net profit declines 24.12% in the September 2025 quarter

Lincoln Pharmaceuticals consolidated net profit declines 24.12% in the September 2025 quarter

Last Updated : Nov 13 2025 | 3:34 PM IST

Sales rise 1.33% to Rs 163.36 crore

Net profit of Lincoln Pharmaceuticals declined 24.12% to Rs 19.98 crore in the quarter ended September 2025 as against Rs 26.33 crore during the previous quarter ended September 2024. Sales rose 1.33% to Rs 163.36 crore in the quarter ended September 2025 as against Rs 161.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales163.36161.21 1 OPM %15.5717.60 -PBDT32.4338.01 -15 PBT28.8134.78 -17 NP19.9826.33 -24

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content